TransCode Therapeutics, Inc. (RNAZ)
NASDAQ: RNAZ · Real-Time Price · USD
6.21
+0.97 (18.51%)
At close: Jun 30, 2026, 4:00 PM EDT
6.14
-0.07 (-1.13%)
After-hours: Jun 30, 2026, 6:38 PM EDT
TransCode Therapeutics Market Cap
TransCode Therapeutics has a market cap or net worth of $5.9 million as of June 30, 2026. Its market cap has decreased by -6.36% in one year.
Market Cap
5.90M
Enterprise Value
-7.98M
1-Year Change
-6.36%
Ranking
Category
Stock Price
$6.21
Market Cap Chart
Since the IPO on July 9, 2021, TransCode Therapeutics's market cap has decreased from $47.87M to $5.90M, a decrease of -87.67%. That is a compound annual growth rate of -34.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 5.90M | -5.77% |
| Dec 31, 2025 | 6.26M | 166.92% |
| Dec 31, 2024 | 2.35M | -43.27% |
| Dec 29, 2023 | 4.14M | -51.10% |
| Dec 30, 2022 | 8.46M | -73.50% |
| Dec 31, 2021 | 31.92M | -33.32% |
| Jul 9, 2021 | 47.87M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dermata Therapeutics | 5.19M |
| PMGC Holdings | 5.18M |
| Processa Pharmaceuticals | 5.12M |
| Alaunos Therapeutics | 5.04M |
| CollPlant Biotechnologies | 4.80M |
| Liminatus Pharma | 4.74M |
| GeoVax Labs | 4.58M |
| Alzamend Neuro | 4.57M |